Home
>
National Drug Code (NDC)
>
Clindamycin
Clindamycin - 25021-115-02 - (Clindamycin Phosphate)
Drug Information of Clindamycin
| Product NDC: | 25021-115 |
| Proprietary Name: | Clindamycin |
| Non Proprietary Name: | Clindamycin Phosphate |
| Active Ingredient(s): | 150 mg/mL & nbsp; Clindamycin Phosphate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Clindamycin
| Product NDC: | 25021-115 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090109 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120515 |
Package Information of Clindamycin
| Package NDC: | 25021-115-02 |
| Package Description: | 25 VIAL in 1 CARTON (25021-115-02) > 2 mL in 1 VIAL |
NDC Information of Clindamycin
| NDC Code | 25021-115-02 |
| Proprietary Name | Clindamycin |
| Package Description | 25 VIAL in 1 CARTON (25021-115-02) > 2 mL in 1 VIAL |
| Product NDC | 25021-115 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Clindamycin Phosphate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120515 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | CLINDAMYCIN PHOSPHATE |
| Strength Number | 150 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |
